Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

PLoS Med · 2007 · PMC1796909 · PMID 17298168

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0550

boldest claim

The sentences

highly significantp < 0.001actually significant

Protection of vaccinated mice against mortality from the homologous virus was highly significant ( p < 0.001), which demonstrates the vaccine's potency.

also in 132,142 other papers

approached significancep = 0.051so close (0.05 < p ≤ 0.1)

Owing to small treatment groups in this experiment, the difference in mortality between mice receiving huN1 DNA (4/8) versus saline (1/7) was not statistically significant ( p = 0.18), but the difference between huN1 DNA and empty vector treatment (0/7) approached significance ( p = 0.051).

also in 8,237 other papers

did not reach statistical significancep = 0.055so close (0.05 < p ≤ 0.1)

The difference in mortality between immunized and control groups upon heterologous PR8-avN1 challenge approached but did not reach statistical significance ( p = 0.055).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.